Literature DB >> 2600425

Comparison of immunoglobulin binding capacities and ligand leakage using eight different protein A affinity chromatography matrices.

P Füglistaller1.   

Abstract

The capacities of eight protein A affinity chromatography matrices were determined in a column using a purified monoclonal mouse IgG3 antibody. The capacities ranged from 0.5 to 20 mg IgG3/ml gel. Protein A-Sepharose Fast Flow exhibited the highest capacity. Each column was tested for leakage of protein A in the presence or absence of IgG3 at pH 8.9, 4.0 and 3.0. In the absence of immunoglobulins significant leakage could only be detected at pH 8.9. In the presence of immunoglobulins, considerable leakage was also found at pH 4.0, the point at which the immunoglobulins eluted. Depending on the matrix used, the IgG3 eluted from the protein A columns exhibited a contamination of 1.8-88 ppm (weight/weight) protein A. Amongst the gels with IgG3 capacities greater than 10 mg/ml, the least contamination with protein A was observed in the IgG3 fractions from immobilized rProtein A and Protein A-Sepharose CL-4B (Fermentech).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600425     DOI: 10.1016/0022-1759(89)90350-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Tryptophan complexed hydroxyapatite nanoparticles for immunoglobulin adsorption.

Authors:  Sunita Prem Victor; Chandra P Sharma
Journal:  J Mater Sci Mater Med       Date:  2011-07-31       Impact factor: 3.896

2.  Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats.

Authors:  J B C Carvalheira; E B Ribeiro; E P Araújo; R B Guimarães; M M Telles; M Torsoni; J A R Gontijo; L A Velloso; M J A Saad
Journal:  Diabetologia       Date:  2003-11-05       Impact factor: 10.122

Review 3.  Challenges and opportunities in the purification of recombinant tagged proteins.

Authors:  Ana Sofia Pina; Christopher R Lowe; Ana Cecília A Roque
Journal:  Biotechnol Adv       Date:  2013-12-12       Impact factor: 14.227

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.